Shares of RTW Biotech Opportunities (LON:RTW – Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as GBX 1.94 and last traded at GBX 1.93, with a volume of 14163563 shares. The stock had previously closed at GBX 1.89.
RTW Biotech Opportunities Trading Down 0.5%
The stock has a market capitalization of £6.27 million, a price-to-earnings ratio of -0.07 and a beta of 0.60. The firm’s fifty day moving average price is GBX 1.69 and its 200 day moving average price is GBX 1.43.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Featured Articles
- Five stocks we like better than RTW Biotech Opportunities
- What is the NASDAQ Stock Exchange?
- Why Gold Loves Trump as Much as Trump Loves Gold
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- How to Most Effectively Use the MarketBeat Earnings Screener
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
